William Porr, MD
Pulmonary Disease · Mobile, ALNPI 1104074236
Payments from drug & device makers
Across 293 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$1K
- Boehringer Ingelheim$798
- AstraZeneca$559
- Actelion Pharmaceuticals US, Inc.$354
- Grifols USA, LLC$288
- Genentech USA, Inc.$244
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,68596%
- Education$1944%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 77 | $1,122 |
| Boehringer Ingelheim | 50 | $798 |
| AstraZeneca(2 entities) | 37 | $559 |
| Actelion Pharmaceuticals US, Inc. | 15 | $354 |
| Grifols USA, LLC | 20 | $288 |
| Genentech USA, Inc. | 16 | $244 |
| Sunovion Pharmaceuticals Inc. | 16 | $208 |
| Mallinckrodt Hospital Products Inc. | 5 | $198 |
| Merck | 4 | $150 |
| Insmed, Inc. | 4 | $140 |
| Electromed, Inc. | 11 | $132 |
| Regeneron Healthcare Solutions, Inc. | 6 | $116 |
| Sanofi | 6 | $104 |
| Gilead | 4 | $95 |
| Mylan Specialty L.p. | 5 | $82 |
| United Therapeutics Corporation | 3 | $56 |
| Mallinckrodt Enterprises LLC | 2 | $42 |
| Pulmonx Corporation | 2 | $38 |
| Johnson & Johnson | 2 | $26 |
| Optinose US, Inc. | 2 | $24 |
| Philips North America LLC | 1 | $23 |
| Bayer | 1 | $21 |
| Amgen | 1 | $18 |
| Circassia Inc. | 1 | $16 |
| AbbVie | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZERBAXA$102
How this compares
$4,879 in reported general payments places this provider in the 55th percentile of 215 pulmonary disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Mobile
- Allan SeibertMobile$2.4M
- Adrian DivittorioMobile$212K
- Peter LutzMobile$102K
- Johnson HaynesMobile$50K
- Virginia RadcliffMobile$23K
- Brian FoutyMobile$21K
- Cynthia CrowderMobile$20K
- Philip AlmaloufMobile$14K
- Campbell SindelMobile$14K
- Chibuzo OdigweMobile$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.